Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nazir Ismail

Showing results (11-20 of 79) with videos related to

Pageof 8
Sort By:
PLOS Global Public Health|June 11, 2025
WHO target product profile for TB detection at peripheral settings: 2024 updateMikashmi Kohli, Alexei Korobitsyn, Nazir Ismail, et al.
BMC Public Health|December 7, 2019
Data quality of drug-resistant tuberculosis and antiretroviral therapy electronic registers in South AfricaLise Jamieson, Denise Evans, Rebecca Berhanu, et al.
The Lancet. Infectious Diseases|March 6, 2022
25 years of surveillance of drug-resistant tuberculosis: achievements, challenges, and way forwardAnna S Dean, Olga Tosas Auguet, Philippe Glaziou, et al.
African Journal of Laboratory Medicine|December 21, 2018
Drug resistant tuberculosis in Africa: Current status, gaps and opportunitiesNazir Ismail, Farzana Ismail, Shaheed V Omar, et al.
Plos One|May 3, 2017
A combination of baseline plasma immune markers can predict therapeutic response in multidrug resistant tuberculosisSelena Ferrian, Claudia Manca, Sugnet Lubbe, et al.
BMC Public Health|July 24, 2019
Treatment outcomes among children, adolescents, and adults on treatment for tuberculosis in two metropolitan municipalities in Gauteng Province, South AfricaKaitlyn M Berry, Carly A Rodriguez, Rebecca H Berhanu, et al.
The Lancet. Global Health|June 14, 2024
Trade-offs between clinical performance and test accessibility in tuberculosis diagnosis: a multi-country modelling approach for target product profile developmentAlexandra de Nooy, Tom Ockhuisen, Alexei Korobitsyn, et al.
Paediatrics and International Child Health|November 1, 2018
Diagnostic strategies for childhood tuberculosis in the context of primary care in a high burden setting: the value of alternative sampling methodsColleen F Hanrahan, Heather Dansey, Lillian Mutunga, et al.
Eclinicalmedicine|January 16, 2026
Cost and impact of decentralized tuberculosis testing: a modeling analysis of price thresholds for molecular instruments in high-burden settingsTom Ockhuisen, Alexandra de Nooy, Sarah Girdwood, et al.
Plos One|June 21, 2016
Cost-Effectiveness of Automated Digital Microscopy for Diagnosis of Active TuberculosisSwati Jha, Nazir Ismail, David Clark, et al.
Pageof 8

Showing results (11-20 of 79) with videos related to

Sort By:
Pageof 8
PLOS Global Public Health|June 11, 2025
WHO target product profile for TB detection at peripheral settings: 2024 updateMikashmi Kohli, Alexei Korobitsyn, Nazir Ismail, et al.
BMC Public Health|December 7, 2019
Data quality of drug-resistant tuberculosis and antiretroviral therapy electronic registers in South AfricaLise Jamieson, Denise Evans, Rebecca Berhanu, et al.
The Lancet. Infectious Diseases|March 6, 2022
25 years of surveillance of drug-resistant tuberculosis: achievements, challenges, and way forwardAnna S Dean, Olga Tosas Auguet, Philippe Glaziou, et al.
African Journal of Laboratory Medicine|December 21, 2018
Drug resistant tuberculosis in Africa: Current status, gaps and opportunitiesNazir Ismail, Farzana Ismail, Shaheed V Omar, et al.
Plos One|May 3, 2017
A combination of baseline plasma immune markers can predict therapeutic response in multidrug resistant tuberculosisSelena Ferrian, Claudia Manca, Sugnet Lubbe, et al.
BMC Public Health|July 24, 2019
Treatment outcomes among children, adolescents, and adults on treatment for tuberculosis in two metropolitan municipalities in Gauteng Province, South AfricaKaitlyn M Berry, Carly A Rodriguez, Rebecca H Berhanu, et al.
The Lancet. Global Health|June 14, 2024
Trade-offs between clinical performance and test accessibility in tuberculosis diagnosis: a multi-country modelling approach for target product profile developmentAlexandra de Nooy, Tom Ockhuisen, Alexei Korobitsyn, et al.
Paediatrics and International Child Health|November 1, 2018
Diagnostic strategies for childhood tuberculosis in the context of primary care in a high burden setting: the value of alternative sampling methodsColleen F Hanrahan, Heather Dansey, Lillian Mutunga, et al.
Eclinicalmedicine|January 16, 2026
Cost and impact of decentralized tuberculosis testing: a modeling analysis of price thresholds for molecular instruments in high-burden settingsTom Ockhuisen, Alexandra de Nooy, Sarah Girdwood, et al.
Plos One|June 21, 2016
Cost-Effectiveness of Automated Digital Microscopy for Diagnosis of Active TuberculosisSwati Jha, Nazir Ismail, David Clark, et al.
Pageof 8